and Vector Pharma FZCO of Dubai UAE, the leading full-service distributor for rare disease, oncology, and highly specialized therapeutics in the Middle East, North Africa and Turkish markets ...

Vector Pharma was founded in 2019 with the ambition to be the leading full service distributor for rare diseases, oncology and highly specialized therapeutics in the Middle East, North Africa, and ...

DUBAI, United Arab Emirates and STOCKHOLM, Sweden, March 27, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO ...